SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006492
Filing Date
2022-04-29
Accepted
2022-04-29 16:16:59
Documents
4
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220616xdef14a.htm DEF 14A 577532
2 GRAPHIC tmb-20220616xdef14a006.jpg GRAPHIC 126479
3 GRAPHIC tmb-20220616xdef14a005.jpg GRAPHIC 165579
4 GRAPHIC tmb-20220616xdef14a001.jpg GRAPHIC 6045
  Complete submission text file 0001558370-22-006492.txt   989526
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40949 | Film No.: 22875692
SIC: 7372 Services-Prepackaged Software